Healthcare

HR 4541, the EARLY Act Reauthorization of 2025, extends the funding period for the Young Women’s Breast Health Education and Awareness program. It amends the Public Health Service Act to update the program’s expiration date from 2026 to 2031. The bill directly affects young women aged 15-25 by ensuring continued access to breast health education and awareness resources. The key provision is a simple extension of the existing program’s authorization period, without altering its scope or requirements. This is a procedural reauthorization to maintain current services through 2031.

This bill, known as the Putting Patients First by Strengthening Provider Accountability in FECA Act, aims to improve oversight of healthcare providers who receive payments under the Federal Employees Health Benefits program. It directly affects medical service providers, suppliers, and the Department of Labor by introducing a new rule that allows the Secretary of Labor to suspend payments to any provider convicted of fraud in this program, federal health care benefit programs, or similar state programs. The law requires the Secretary to issue regulations to enforce this suspension authority and specifies that the changes will take effect 180 days after the bill is enacted.

The Take Care of America's Veterans Act is a comprehensive legislative bill designed to improve benefits, healthcare access, and administrative efficiency for veterans and their families. The bill directly affects veterans, their surviving spouses, caregivers, and the Department of Veterans Affairs (VA). Key provisions include expanding disability compensation for combat-related retirees, allowing remarried surviving spouses to retain certain survivor benefits, and increasing compensation rates for specific disability conditions like sleep apnea and tinnitus. The legislation also mandates significant healthcare improvements, such as establishing a pilot program to coordinate care between the VA and Medicare, creating a formulary for prosthetic items, and requiring the VA to provide lactation spaces in all medical centers. Additionally, the bill introduces administrative reforms to speed up claims processing, prohibit denying claims solely for missed medical appointments, and enhance oversight of the VA's disability rating system.

HR 8469 is an appropriations bill that allocates federal funds for military construction, the Department of Veterans Affairs (VA), and several related agencies for the fiscal year ending September 30, 2027. The bill provides substantial funding for military construction projects across all service branches, including new facilities, upgrades, and family housing for military personnel and their families. It also dedicates significant resources to the Department of Veterans Affairs to support a wide range of veterans' benefits, healthcare services (including community care, mental health, and care for toxic exposures), medical research, and the modernization of the veterans' electronic health record system. Additionally, the bill funds national cemeteries, the US Court of Appeals for Veterans Claims, and the American Battle Monuments Commission, while setting administrative rules and conditions for how these funds can be obligated and spent. This legislation directly affects military members, veterans, and their families by providing the financial resources for their infrastructure, healthcare, and benefit programs.

This bill authorizes the Department of Veterans Affairs to construct a major medical facility project in St. Louis, Missouri, during fiscal year 2026. It specifically funds a new bed tower, expanded clinical buildings, a consolidated administrative building, warehouse, utility plant, and parking garages, with a maximum funding limit of $1,762,668,000. The bill directly affects veterans receiving care at the St. Louis VA medical facility by enabling physical infrastructure upgrades. It does not change existing VA benefits or policies but provides the necessary funding authorization for these construction projects. The authorization is for fiscal year 2026, not fiscal year 2025 as referenced in the bill's title.

This bill reauthorizes three existing rural health care grant programs under the Public Health Service Act through 2030, extending funding from the previous 2021-2025 period. It requires all funded projects to directly serve rural underserved populations and involve these communities in planning, development, and operations. The programs support rural clinics, health networks, and quality improvement initiatives to expand access to care in underserved areas. Funding will now continue through 2030, maintaining critical support for rural health providers.

HR 3492, the Protect Children’s Innocence Act, makes it a federal crime to perform genital or bodily mutilation or chemical castration on minors under 18, except for specific medical reasons. The bill broadly defines prohibited procedures to include gender transition-related surgeries (like hysterectomies or mastectomies) and medical treatments such as puberty blockers or cross-sex hormones administered to minors. It criminalizes these acts when they occur across state lines, involve payments, or use interstate commerce, while explicitly banning religious tradition as a defense. Exceptions include medically necessary procedures for health emergencies, childbirth, or conditions certified by a physician.

HR 498, the "Do No Harm in Medicaid Act," prohibits federal Medicaid funding for gender transition procedures for individuals under 18 years old. The bill amends the Social Security Act to define "specified gender transition procedures" broadly, including surgeries, hormone treatments, and certain medications, and bans federal Medicaid coverage for these services for minors. Exceptions are made only for medically necessary treatments related to precocious puberty, genetic disorders of sex development, or urgent medical conditions requiring bodily correction (like infections or injuries from prior procedures). This directly affects minors enrolled in Medicaid state plans, as states would no longer receive federal funds for these specific covered services.

This bill creates a program to assign traveling physicians to provide healthcare services to veterans residing in U.S. territories, including Puerto Rico, Guam, American Samoa, and the U.S. Virgin Islands. It allows the Department of Veterans Affairs (VA) to assign physicians for up to one year at VA facilities in these territories, requiring coordination with local medical providers to ensure quality care. Physicians assigned under this program would receive a relocation or retention bonus similar to existing federal employee incentives. The bill directly affects veterans in U.S. territories and VA healthcare operations there.

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This act permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Under the act, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term). Additionally, the act establishes a new, alternative registration process for certain schedule I research. The act also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the act expresses the sense that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray , a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.